about
MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF-Mutated Colorectal Cancer.BRAF V600E is a determinant of sensitivity to proteasome inhibitorsBirthweight, maternal weight trajectories and global DNA methylation of LINE-1 repetitive elementsLeukocyte DNA as surrogate for the evaluation of imprinted Loci methylation in mammary tissue DNA.Aberrant methylation of imprinted genes is associated with negative hormone receptor status in invasive breast cancerThe prevalence of loss of imprinting of H19 and IGF2 at birth.Digital PCR assessment of MGMT promoter methylation coupled with reduced protein expression optimises prediction of response to alkylating agents in metastatic colorectal cancer patients.Tumor MGMT promoter hypermethylation changes over time limit temozolomide efficacy in a phase II trial for metastatic colorectal cancer.Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer.Immunogenic death of colon cancer cells treated with oxaliplatin.Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer.Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer.Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth.Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers.Colorectal cancer early methylation alterations affect the crosstalk between cell and surrounding environment, tracing a biomarker signature specific for this tumor.Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylationWhole exome sequencing analysis of urine trans-renal tumour DNA in metastatic colorectal cancer patientsRefining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferaseCapecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal CancerHigh Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With RegorafenibA Genomic Analysis Workflow for Colorectal Cancer Precision OncologyEvolving neoantigen profiles in colorectal cancers with DNA repair defects
P50
Q27853393-E41C44A6-1098-4812-B74C-EB5E2154FA86Q28300004-B1CCE599-3119-4603-A5AA-9FD8BC2EDC05Q34043005-8712F906-874A-426E-A351-70279B6D3A1BQ34586415-01CFF6C6-04D6-44E4-8663-D1C6D966C28AQ35624942-5B1AD8C0-3B53-4BC0-A772-8AB28F9C187CQ37022907-CC79729A-AF38-4213-8DD9-F5EF3452FC2CQ38376701-32DA7676-DFC6-4601-9888-0EA081297B48Q38381989-4972259E-689B-42CE-B828-953B1566143BQ38764035-4140F1A5-ABAB-4E35-8F1B-88C16098C192Q39780621-30832C48-8184-42FD-9CB5-F7C13366AE95Q40291585-B67D68AE-96BC-488E-9787-7CBCFA873305Q46213853-B4CCEF3B-94CF-4F91-B6BE-E09F787DC9E2Q49551908-860E1D9E-3EE5-4627-BC24-0535C1B2B936Q51717752-7083EB1D-9F34-432A-9672-87A06D3BB42BQ53433810-19400FA0-20E7-4810-94A9-A16F767A60CFQ88961041-9E0A611D-01AA-4B2F-B5BE-B3B538C97929Q90156140-8A498681-676E-4E1D-ADF7-9A0738FBAD74Q90716197-A1E0F78F-7E05-4441-9A7F-5D951DCC9C7EQ91329177-E0066B79-2F9F-4438-9AA1-95A901EF329CQ92242802-5BA31876-BBCA-4A03-BB59-45C9712133F8Q93074969-BF234EAB-F8F5-4277-A087-BDBB3EDDB24EQ93111962-E1BD8E6D-9CF3-4D4C-B79E-D4149C1F98F2
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ludovic Barault
@ast
Ludovic Barault
@en
Ludovic Barault
@es
Ludovic Barault
@nl
Ludovic Barault
@sl
type
label
Ludovic Barault
@ast
Ludovic Barault
@en
Ludovic Barault
@es
Ludovic Barault
@nl
Ludovic Barault
@sl
prefLabel
Ludovic Barault
@ast
Ludovic Barault
@en
Ludovic Barault
@es
Ludovic Barault
@nl
Ludovic Barault
@sl
P108
P1053
J-2472-2016
P106
P108
P1153
24070031200
P21
P31
P3829
P496
0000-0001-5227-5047